The Dreamer Girls Project: Adaptation of SISTA/SIHLE for HIV/AIDS and Substance Abuse Prevention Among Black Adolescent Girls

ConditionHIV/AIDS
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age13-18
SponsorYale University

About this trial

The study will use focus group methodology in the formative evaluation phase. Focus group methodology provides a rich source of data and understanding of phenomena by allowing the researcher to examine the interaction among participants

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Identify as a Black/African American female

Be between the ages of 13-18 years old;

Consent to being a part of the study (Parent consent and youth assent if under 18 years old);

Live in Paterson, New Jersey at the time of the study;

Disqualifiers

not identify as Black/African American only

be under the age of 13 or over the age of 18

no parental consent provided

no youth assent provided

Trial design

Design model

Single group

Treatments tested in this trial

  • Theater/Pilot Testing

    Other intervention

    Participants will take part in a theater/pilot testing in order to receive adequate feedback and make substantive change in the intervention

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Theater/Pilot TestingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in 30-day drug use

Past 30-day drug use will be measured using items from the National Survey on Drug Use and Health (Substance Abuse and Mental Health Services Administration, 2006) and Youth Risk Behavior Survey. The scale consisted of three items that assesses how often participants smoked cigarettes, drank alcohol, and smoked marijuana in the past 30 days. An example of an item is, "Estimate the number of days you used marijuana or hashish in the last 30 days." Participants responded to these items on a 7-point scale (1 = 0 days; 2 =1-2 days, 3 = 3-5 days; 4 = 6-9 days; 5 = 10-19 days; 6 = 20-29 days; 7 = All 30 days). The sum of this scale is the mean of responses on the three items, with higher scores indicating greater frequency of use.

Time frame
30 days
2

Change in perception of drug use risk

To assess the perceived risk of using alcohol, tobacco, and marijuana, adapted questions from the Monitoring the Future study will be used. Questions such as: perceived risk of moderate daily drinking, heavy drinking, combining alcohol with marijuana, daily smoking and heavy, daily and heavy marijuana use. The choices are: 0=Can't Say/Drug Unfamiliar, 1=No risk, 2=Slight risk, 3=Moderate risk, 4=Great risk. All of the items will be summed together. Higher score indicates greater perception of risk from using alcohol and drugs

Time frame
Baseline, 30 days, 60 days
3

Change in perception of sexual risk

Perception of Sexual Risk was assessed using eight items that measured participants' perception of sexual risk (sample item: How much do you think people risk harming themselves physically if they have sex without a condom or dental dam?) and substance use risk (sample item: How much do people risk harming themselves physically or in other ways when they smoke marijuana once or twice a week?). Items will be summed and higher scores will indicate greater perceived risk

Time frame
Baseline, 30 days, 60 days
4

Change in HIV knowledge

HIV Knowledge will be assessed using eight items that measured participants' HIV knowledge (sample item: Only people who look sick can spread the HIV/AIDS virus.). Responses were recorded using True (1) or False (0). Items will be summed and higher scores indicated greater HIV knowledge

Time frame
Baseline, 30 days, 60 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yale University

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: